ArticleCancer medicine2026
Tobacco Use, Knowledge of Harms, and Treatment Support Among Patients With Non-Tobacco-Related Cancers: A Multi-Center Survey Study.
Article in Cancer medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTobacco smoking adversely affects cancer outcomes; yet tobacco treatment for patients with non-tobacco-related cancers (non-TRCs) remains understudied. This study evaluated smoking behaviors, harm perceptions, and cessation support in this population.
methodsWe conducted a cross-sectional survey of 124 adults who reported smoking within the past 30 days and were diagnosed with non-TRCs at two medical centers between 2018 and 2022. Data collected included demographics, smoking behaviors, harm perceptions, quit attempts, and receipt of cessation support from oncology providers.
resultsMost participants (88%) recognized that continued smoking may shorten life expectancy; however, fewer recognized its impact on cancer recurrence (44%), treatment efficacy (46%), and treatment-related side effects (46%). Although 81% reported prior quit attempts, only 33% received prescription medication and 22% received counseling. Follow-up support from oncology teams was reported by 42% of participants.
conclusionPatients with non-TRCs demonstrate substantial gaps in awareness of the cancer-specific harms of continued smoking and report inconsistent receipt of evidence-based cessation support. Targeted education and systematic integration of tobacco treatment into oncology care are needed to improve outcomes in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.